Institutional Desk

GlobeNewsInfo Editorial Team

A collective syndicate of journalists, sector analysts, and market researchers dedicated to providing verified, objective intelligence across key global economic sectors.

The GlobeNewsInfo Editorial Team is responsible for researching, verifying, editing and publishing business news and intelligence covering Investments, Infrastructure, Finance, Energy, Technology, Health & Medical, Transportation, Defence, Food & Agriculture, Projects, Contracts & Procurements, Corporate Developments, Manufacturing, Mergers & Acquisitions and other major economic and industry developments.

Our editorial team focuses on presenting business information in a clear, factual and concise manner, helping readers understand significant developments across companies, industries, markets and regions. GlobeNewsInfo aims to provide original and informative business news content based on publicly available information and credible sources.

Our Editorial Process

Our editorial process generally involves structural peer checks and multi-stage verification:

Research

We identify and review relevant information from official announcements and other credible sources.

Verification

Key facts are reviewed against available source information.

Context and Analysis

Where appropriate, articles provide additional context on the potential significance of a development, including its relevance to industries, companies, regions and infrastructure markets.

Editing and Review

Articles are reviewed for clarity, accuracy, consistency, grammar and adherence to GlobeNewsInfo's editorial standards before publication.

Sources and Attribution

GlobeNewsInfo uses information from a range of publicly available and authoritative sources. Depending on the nature of a story, these may include government departments and agencies, public procurement authorities, companies, stock exchanges and regulatory bodies, development institutions, project authorities, official corporate announcements and other credible sources.

Accuracy and Corrections

GlobeNewsInfo makes reasonable efforts to ensure that published information is accurate at the time of publication. However values, timelines, status, company announcements and other business information can change after publication. When a material factual error is identified, GlobeNewsInfo seeks to correct the information promptly.

Readers who identify a potential factual error or have information that may help improve the accuracy of an article are encouraged to contact us.

Use of Technology and AI

GlobeNewsInfo may use technology and AI-assisted tools as part of its research, content processing, editing and publishing workflows.

However, AI-assisted tools are used to support the editorial process and do not replace editorial responsibility. Published content remains subject to human editorial review, fact-checking and approval.

Contact the Editorial Team

For corrections, factual clarifications, source information or other editorial matters, please contact the GlobeNewsInfo editorial team through our Contact Us page.

Author Portfolio

Latest Articles & Coverage

Showing recent intelligence briefings

Health & Medical 2 hours ago

Skanska secures NOK 320 million healthcare construction project in Norway

Skanska has secured a NOK 320 million contract to design and construct the Langevann healthcare center in Egersund, Norway. The 8,000-square-meter facility will consolidate municipal healthcare and care services, including a 60-room nursing home. Construction is scheduled to start in November 2026, with completion targeted for January 2029.

3 min read Read Briefing

Health & Medical 2 hours ago

Labcorp executes 722 million dollar asset purchase agreement to acquire BioReference diagnostics units from OPKO Health

Labcorp has agreed to acquire select diagnostic assets of BioReference Health from OPKO Health for 722 million US dollars in cash, plus earnout payments up to 150 million US dollars. The transaction encompasses clinical testing, women's health, urology, correctional diagnostics, and the FDA-approved 4Kscore Test.

3 min read Read Briefing

Health & Medical 2 hours ago

Mankind Pharma enters oncology cell therapy market with 48 million euro acquisition of Armed Cell Therapeutics

Mankind Pharma has agreed to acquire a 70% majority stake in Belgian biotechnology firm Armed Cell Therapeutics for 48 million euros. The deal establishes Mankind's entry into next-generation CAR-T cell therapies for blood and solid tumor cancers, supporting its international oncology innovation strategy.

3 min read Read Briefing